NO991942L - FremgangsmÕte for fremstilling av malonat metyliden nanopartikler, nanopartikler eventuelt inneholdende ett eller flere biologisk aktive molekyler - Google Patents

FremgangsmÕte for fremstilling av malonat metyliden nanopartikler, nanopartikler eventuelt inneholdende ett eller flere biologisk aktive molekyler

Info

Publication number
NO991942L
NO991942L NO991942A NO991942A NO991942L NO 991942 L NO991942 L NO 991942L NO 991942 A NO991942 A NO 991942A NO 991942 A NO991942 A NO 991942A NO 991942 L NO991942 L NO 991942L
Authority
NO
Norway
Prior art keywords
nanoparticles
methylidene
malonate
preparation
biologically active
Prior art date
Application number
NO991942A
Other languages
English (en)
Other versions
NO991942D0 (no
Inventor
Nicole Bru-Magniez
Xavier Guillon
Pascal Breton
Patrick Couvreur
Francois Lescure
Claude Roques-Carmes
Gerard Riess
Original Assignee
Virsol
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virsol filed Critical Virsol
Publication of NO991942D0 publication Critical patent/NO991942D0/no
Publication of NO991942L publication Critical patent/NO991942L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F22/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides or nitriles thereof
    • C08F22/10—Esters
    • C08F22/12—Esters of phenols or saturated alcohols
    • C08F22/14—Esters having no free carboxylic acid groups
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Nanotechnology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Optics & Photonics (AREA)
  • Biomedical Technology (AREA)
  • Polymers & Plastics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Preparation (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
NO991942A 1996-10-25 1999-04-23 FremgangsmÕte for fremstilling av malonat metyliden nanopartikler, nanopartikler eventuelt inneholdende ett eller flere biologisk aktive molekyler NO991942L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9613039A FR2755136B1 (fr) 1996-10-25 1996-10-25 Procede de preparation de nanoparticules de methylidene malonate, nanoparticules contenant eventuellement une ou plusieurs molecules biologiquement actives et compositions pharmaceutiques les contenant
PCT/FR1997/001907 WO1998018455A1 (fr) 1996-10-25 1997-10-24 Procede de preparation de nanoparticules de methylidene malonate, nanoparticules contenant eventuellement une ou plusieurs molecules biologiquement actives

Publications (2)

Publication Number Publication Date
NO991942D0 NO991942D0 (no) 1999-04-23
NO991942L true NO991942L (no) 1999-06-23

Family

ID=9497032

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991942A NO991942L (no) 1996-10-25 1999-04-23 FremgangsmÕte for fremstilling av malonat metyliden nanopartikler, nanopartikler eventuelt inneholdende ett eller flere biologisk aktive molekyler

Country Status (23)

Country Link
US (2) US6211273B1 (no)
EP (1) EP0934059B1 (no)
JP (1) JP2001504530A (no)
KR (1) KR20000052813A (no)
CN (1) CN1237903A (no)
AR (1) AR009127A1 (no)
AT (1) ATE245171T1 (no)
AU (1) AU736097B2 (no)
BR (1) BR9712372A (no)
CA (1) CA2269783C (no)
CZ (1) CZ144099A3 (no)
DE (1) DE69723571T2 (no)
FR (1) FR2755136B1 (no)
HU (1) HUP9904359A3 (no)
IL (1) IL129355A0 (no)
NO (1) NO991942L (no)
NZ (1) NZ335094A (no)
PL (1) PL332957A1 (no)
RU (1) RU2214421C2 (no)
SK (1) SK55599A3 (no)
TW (1) TW503109B (no)
WO (1) WO1998018455A1 (no)
ZA (1) ZA979550B (no)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2774096B1 (fr) * 1998-01-29 2000-04-07 Virsol Nouveaux copolymeres tensioactifs a base de methylidene malonate
FR2778100B1 (fr) * 1998-04-29 2001-05-04 Virsol Nouvelles microspheres a base de poly(methylidene malonate), leur procede de preparation et compositions pharmaceutiques les contenant
FR2789314B1 (fr) * 1999-02-09 2001-04-27 Virsol Materiau de suture de plaies a base de methylidene malonate
KR20020093903A (ko) * 2000-04-12 2002-12-16 다이니혼 잉키 가가쿠 고교 가부시키가이샤 오염방지 도료 조성물 및 신규 수지
JP4611561B2 (ja) * 2000-04-12 2011-01-12 Ｄｉｃ株式会社 新規なビニル系樹脂およびその製造方法
FR2812551B1 (fr) * 2000-08-07 2003-03-28 Virsol Forme pharmaceutique comprenant un materiau support a base de methylidene malonate et un facteur de regulation cellulaire
US20030008015A1 (en) * 2000-10-11 2003-01-09 Levisage Catherine S. Polymer controlled delivery of a therapeutic agent
KR100457824B1 (ko) * 2001-08-10 2004-11-18 한국화학연구원 용액 열분해법에 의한 나노 크기 2가 금속 산화물 분말의제조
JP3961312B2 (ja) 2002-02-26 2007-08-22 株式会社デンソー 内燃機関の制御装置
WO2008018932A2 (en) * 2006-05-01 2008-02-14 The Board Of Trustees Of The Leland Stanford Junior University Method and use of nano-scale devices for reduction of tissue injury in ischemic and reperfusion injury
EP2123262A1 (en) 2008-05-20 2009-11-25 Consorzio per il Centro di Biomedica Moleculare Scrl Polyelectrolyte-encapsulated gold nanoparticles capable of crossing blood-brain barrier
US8975435B2 (en) * 2009-05-07 2015-03-10 Optmed, Inc. Methylidene malonate process
US8106234B2 (en) * 2009-05-07 2012-01-31 OptMed, Inc Methylidene malonate process
US9828324B2 (en) 2010-10-20 2017-11-28 Sirrus, Inc. Methylene beta-diketone monomers, methods for making methylene beta-diketone monomers, polymerizable compositions and products formed therefrom
US9279022B1 (en) * 2014-09-08 2016-03-08 Sirrus, Inc. Solution polymers including one or more 1,1-disubstituted alkene compounds, solution polymerization methods, and polymer compositions
US9249265B1 (en) * 2014-09-08 2016-02-02 Sirrus, Inc. Emulsion polymers including one or more 1,1-disubstituted alkene compounds, emulsion methods, and polymer compositions
US10414839B2 (en) 2010-10-20 2019-09-17 Sirrus, Inc. Polymers including a methylene beta-ketoester and products formed therefrom
EP2630116B1 (en) 2010-10-20 2017-09-27 Sirrus, Inc. Synthesis of methylene malonates using rapid recovery in the presence of a heat transfer agent
WO2013059473A2 (en) 2011-10-19 2013-04-25 Bioformix Inc. Multifunctional monomers, methods for making multifunctional monomers, polymerizable compositions and products formed therefrom
EP2831185B1 (en) 2012-03-30 2019-09-25 Sirrus, Inc. Ink and coating formulations and polymerizable systems for producing the same
EP3153530B1 (en) 2012-03-30 2021-02-24 Sirrus, Inc. Composite and laminate articles and polymerizable systems for producing the same
WO2013149165A1 (en) 2012-03-30 2013-10-03 Bioformix Inc. Methods for activating polymerizable compositions, polymerizable systems, and products formed thereby
WO2013181600A2 (en) 2012-06-01 2013-12-05 Bioformix Inc. Optical material and articles formed therefrom
EP2920231B1 (en) 2012-11-16 2020-05-06 Sirrus, Inc. Plastics bonding systems and methods
CN105164797B (zh) 2012-11-30 2019-04-19 瑟拉斯公司 用于电子应用的复合组合物
EP2943462B1 (en) 2013-01-11 2018-06-27 Sirrus, Inc. Method to obtain methylene malonate via bis(hydroxymethyl) malonate pathway
US9315597B2 (en) 2014-09-08 2016-04-19 Sirrus, Inc. Compositions containing 1,1-disubstituted alkene compounds for preparing polymers having enhanced glass transition temperatures
US9416091B1 (en) 2015-02-04 2016-08-16 Sirrus, Inc. Catalytic transesterification of ester compounds with groups reactive under transesterification conditions
US10501400B2 (en) 2015-02-04 2019-12-10 Sirrus, Inc. Heterogeneous catalytic transesterification of ester compounds with groups reactive under transesterification conditions
US9334430B1 (en) 2015-05-29 2016-05-10 Sirrus, Inc. Encapsulated polymerization initiators, polymerization systems and methods using the same
US9217098B1 (en) 2015-06-01 2015-12-22 Sirrus, Inc. Electroinitiated polymerization of compositions having a 1,1-disubstituted alkene compound
CN107709378B (zh) * 2015-06-19 2019-06-11 赛鲁斯股份有限公司 用于制备具有增强的玻璃化转变温度的聚合物的含有1,1-二取代的烯烃化合物的组合物
US9518001B1 (en) 2016-05-13 2016-12-13 Sirrus, Inc. High purity 1,1-dicarbonyl substituted-1-alkenes and methods for their preparation
US9617377B1 (en) 2016-06-03 2017-04-11 Sirrus, Inc. Polyester macromers containing 1,1-dicarbonyl-substituted 1 alkenes
US10428177B2 (en) 2016-06-03 2019-10-01 Sirrus, Inc. Water absorbing or water soluble polymers, intermediate compounds, and methods thereof
US9567475B1 (en) 2016-06-03 2017-02-14 Sirrus, Inc. Coatings containing polyester macromers containing 1,1-dicarbonyl-substituted 1 alkenes
US10196481B2 (en) 2016-06-03 2019-02-05 Sirrus, Inc. Polymer and other compounds functionalized with terminal 1,1-disubstituted alkene monomer(s) and methods thereof
WO2018219729A1 (en) 2017-06-02 2018-12-06 Arkema France Curable compositions and uses thereof
WO2020123579A1 (en) * 2018-12-11 2020-06-18 Sirrus, Inc. Polymerization of 1,1-dicarbonyl 1-alkenes
US20220411561A1 (en) 2019-07-19 2022-12-29 Arkema France Curable compositions useful for obtaining non-sensitizing cured products

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4329332A (en) * 1978-07-19 1982-05-11 Patrick Couvreur Biodegradable submicroscopic particles containing a biologically active substance and compositions containing them
FR2611705B1 (fr) * 1987-03-05 1989-07-13 Union Pharma Scient Appl Procede de preparation de monesters ou diesters de l'acide endoethano-9, 10 dihydro-9, 10 anthracene bicarboxylique-11, 11, nouveaux monesters ou diesters ainsi prepares et utilisation de ceux-ci pour la preparation de methylenemalonates symetriques ou asymetriques
FR2722411B1 (fr) * 1994-07-18 1996-10-04 Union Pharma Scient Appl Immunonanoparticules revetues d'anticorps monoclonaux anti-beta2 microglobuline et leur utilisation pour la prophylaxie et/ou le traitement de pathologies dues a une infection par le virus hiv

Also Published As

Publication number Publication date
TW503109B (en) 2002-09-21
DE69723571T2 (de) 2004-06-03
US6420468B2 (en) 2002-07-16
DE69723571D1 (de) 2003-08-21
AU4950997A (en) 1998-05-22
HUP9904359A3 (en) 2000-11-28
AU736097B2 (en) 2001-07-26
ZA979550B (en) 1998-05-12
WO1998018455A1 (fr) 1998-05-07
CA2269783A1 (en) 1998-05-07
NO991942D0 (no) 1999-04-23
RU2214421C2 (ru) 2003-10-20
US6211273B1 (en) 2001-04-03
HUP9904359A2 (hu) 2000-05-28
KR20000052813A (ko) 2000-08-25
ATE245171T1 (de) 2003-08-15
AR009127A1 (es) 2000-03-08
EP0934059A1 (fr) 1999-08-11
BR9712372A (pt) 2000-01-25
US20010006989A1 (en) 2001-07-05
FR2755136A1 (fr) 1998-04-30
CN1237903A (zh) 1999-12-08
IL129355A0 (en) 2000-02-17
PL332957A1 (en) 1999-10-25
SK55599A3 (en) 2000-03-13
EP0934059B1 (fr) 2003-07-16
JP2001504530A (ja) 2001-04-03
FR2755136B1 (fr) 1999-01-22
CZ144099A3 (cs) 1999-09-15
CA2269783C (en) 2005-01-11
NZ335094A (en) 2001-05-25

Similar Documents

Publication Publication Date Title
NO991942L (no) FremgangsmÕte for fremstilling av malonat metyliden nanopartikler, nanopartikler eventuelt inneholdende ett eller flere biologisk aktive molekyler
DE69801973T2 (de) Verfahren zur Herstellung von 1,1,1,3,3-Pentafluorpropan
DE69942641D1 (de) Verfahren zur Herstellung von 1,1,1,3,3-Pentafluorpropan
DE69711120D1 (de) Verfahren zur Herstellung von Dialkylnaphthalinen
DE69938535D1 (de) Dampfphasenprozess zur Herstellung von Aluminid
DE59608829D1 (de) Verfahren zur Herstellung von 1,3-Dimethyl-5-fluor-pyrazol-4-carboxaniliden
ATE253917T1 (de) Nrihydroxstilbene enthaltende produkte und deren derivate und verfahren zur deren herstellung und ihre verwendung
DE69908533D1 (de) Verfahren zur Herstellung von 3,3,5-Trimethylcyclohexylidenebisphenolen
DE69504162D1 (de) Verfahren zur Herstellung von 2-Methyl-1,4-naphthochinon
DE69828191D1 (de) Verfahren zur herstellung von 2,6-dialkylnaphthalin
DE69511788T2 (de) Verfahren zur Herstellung von 1,1,1,3,3-Pentafluorpropan
DE69822711D1 (de) Verfarhen zur Herstellung von Dialkylnaphthalinen
DE69936449D1 (de) Verfahren zur herstellung von 1,3-disubstituierten-4-oxocyclischen harnstoffen
DE69913635D1 (de) Verfahren zur Herstellung von 1,3-Dialkyl-2-Imidazolinonderivaten
DE69920003D1 (de) Verfahren zur herstellung von 1,3-disubstituierten-4-oxocyclischen harnstoffen
DE50000074D1 (de) Verfahren zur Herstellung von halogenierten 1,2-Disilaethanen
DE69801454T2 (de) Verfahren zur Herstellung von 2-Methyl-1,4-Benzochinon
DE69716203D1 (de) Verfahren zur Herstellung von hochreinem 1,3-Dialkyl-2-imidazolidinon
DE59810251D1 (de) Verfahren zur Herstellung von 2,3,4,5-Tetrafluorbenzolderivaten
DE59405716D1 (de) Verfahren zur Herstellung von 1-Cyclopropylalkan-1,3-dionen
DE69802312T2 (de) Verfahren zur Herstellung von 3,3',5,5'-Tetra-b-Butylbiphenol
DE59605866D1 (de) Verfahren zur Herstellung von 2,2-Dialkylaryliden-cycloalkanonen
DE59904904D1 (de) Verfahren zur Herstellung von Phenyldichloro-1,3,5-triazinverbindungen
DE59610341D1 (de) Verfahren zur Herstellung von 2,4,6-Trichlorpyrimidin
DE69813244D1 (de) Verfahren zur Herstellung von Roxithromycin und Derivate davon

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application